Accepted at 9:20 p.m. Dec, 12, 2023 by herstein.jacob
Author: herstein.jacob
Related Note: 1472000189983
Rationale for change

there are like 10 separate reddit posts asking why this happens - figured we should add
Source: Other - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894371/

Extra Extra
Text
What effect do class IC antiarrhythmics have on the effective refractory period in the AV node and accessory bypass tracts?

{{c1::Significant prolongation of ERP}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Physeo
Empty field
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::12_16_Antiarrythmics::12_Class_1_Sodium_Channel_Blockers #AK_Step2_v12::#B&B::02_Cardiology::05_Pharmacology::01_Cardiovascular_Pharmacology_I #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::04_Antiarrhythmics::01_Class_I_A-C #AK_Step1_v12::#Bootcamp::Cardiology::13_Antiarrhythmics::02_Class_I_Antiarrhythmics #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::^Systems::Cardio::Pharmacology !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#OME::PreClinical::Cardiac::Cardiac_5::Electricity::Arrhythmias #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::05_Class_IC_Antiarrhythmics #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::17_Class_IA,_IB,_and_IC_Antiarrhythmics #AK_Step1_v12::#B&B::05_Cardio::04_Arrhythmias::06_Antiarrhythmic_Drugs